Key result
Integrating genetic and epigenetic biomarkers with machine learning improves cardiovascular risk prediction over conventional models.
Why the study?
This review aggregates outcomes from literature predicting CVD to inform future research directions, including validating models across diverse populations and integrating multi-omics data.
Do integrative approaches using machine learning and genetic-epigenetic analyses improve forecasts of adversative cardiovascular events and mortality in cardiovascular disease risk assessment?
Do integrative approaches using machine learning and genetic-epigenetic analyses improve forecasts of adversative cardiovascular events and mortality in cardiovascular disease risk assessment?
Answers are grounded in this paper and cite their sources.
Advanced biomarker studies and machine learning methods improve cardiovascular risk assessment compared to traditional models, potentially enabling tailored preventive programs.
This article reviews the advanced integrative approaches for estimating cardiovascular disease (CVD) risk by means of machine learning and genetic-epigenetic analyses. A methodical review of 35 studies indicating the prognostic value of several biomarkers-including cardiac troponins, and DNA methylation surrogates-is available in various literatures. These biomarkers were found to improve forecasts of adversative cardiovascular (CV) events and mortality and other CV outcomes. Especially in short-term prediction windows, the integrated model composing of genetics-epigenetics proved better than usual risk assessment models. The results from different literature show how well-advanced biomarker studies and machine learning methods might reduce CV risk assessment, opening the path for tailored preventive programs and improved clinical results. This review article aggregates the outcomes of the various literature for the prediction of CVD, so that the validation of these research models in various populations and merging multi-omics data for more general use will become the future research direction.
No takes yet. Share an insight, caveat, or question.
Rajagopal et al. (2024) conducted a review in Cardiovascular disease. Machine learning and genetic-epigenetic biomarker models vs. Conventional risk assessment models was evaluated on Cardiovascular disease risk prediction accuracy. Integrating genetic and epigenetic biomarkers with machine learning techniques improves the sensitivity and specificity of cardiovascular disease risk prediction compared to conventional models.
Synapse has enriched 10 related papers. Consider them for comparative context: